Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study

BackgroundThere is limited information regarding the optimal third-line therapy for managing type 2 diabetes mellitus (T2DM) that is inadequately controlled using dual combination therapy. This study assessed the efficacy and safety of pioglitazone or glimepiride when added to metformin plus aloglip...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Jeong Mi Kim, Sang Soo Kim, Jong Ho Kim, Mi Kyung Kim, Tae Nyun Kim, Soon Hee Lee, Chang Won Lee, Ja Young Park, Eun Sook Kim, Kwang Jae Lee, Young Sik Choi, Duk Kyu Kim, In Joo Kim
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Korean Diabetes Association 2020-02-01
Saila:Diabetes & Metabolism Journal
Gaiak:
dipeptidyl-peptidase iv inhibitors
drug therapy, combination
sulfonylurea compounds
thiazolidinediones
treatment failure
Sarrera elektronikoa:http://e-dmj.org/upload/pdf/dmj-44-67.pdf
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak